Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AKS 440

Next Previous
X
Search
Drug Profile

AKS 440

Alternative Names: AKS-440

Latest Information Update: 04 Apr 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Akston Biosciences
  • Class Antihyperglycaemics; Insulins; Recombinant fusion proteins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Type 1 diabetes mellitus

Most Recent Events

  • 22 Mar 2024 AKS 440 is available for licensing as of 22 Mar 2024. https://www.akstonbio.com/pipelinenew/
  • 11 Mar 2024 Preclinical trials in Type 1 diabetes mellitus in USA (Parenteral) (Akston Biosciences Pipeline, March 2024)
  • 09 Aug 2022 Akston Biosciences has patent protection for " once-a-week insulin Fc-fusion proteins for treating human diabetes and the lead compound covered by it, AKS-440" in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top